In Brief: Menley & James/Rystan
This article was originally published in The Tan Sheet
Executive Summary
Menley & James/Rystan: Menley & James will market Rystan's Derifil internal deodorant beginning the second quarter of 1996. The agreement with Rystan, a GWC Health subsidiary, is Menley & James' third such deal formed this year, reflecting the company's strategy "to use its well-developed national retail distribution system as a platform for profitable growth," according to a May 16 press release. The company says it will "continue to seek other opportunities to advance this strategy"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning